Recent

% | $
Quotes you view appear here for quick access.

OCATA THERAPEUTICS, INC. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • lastbullstanding lastbullstanding Jul 26, 2012 8:21 PM Flag

    Roche has beat ACTC to the macular degeneration injection punch.

    not too mention risk of infection if you half to continously inject, avastin,lucentis both require that anyone who knows anything about ACTC has known about those drugs for a long time and can't even begin to compare with RPE cells if the outcome reaches it's positive potential

 
OCAT
6.240.00(0.00%)Jun 2 4:00 PMEDT